Anemia and Renal Insufficiency – Robert A. Kyle, MD, and Michael Tomasson, MD
Dr. Kyle: Washington University School of Medicine, St. Louis, MO; Dr. Tomasson: Mayo Clinic College of Medicine

Copyright of the American Society of Hematology, 2006. ISSN: 1931-6860.

VIII. BIBLIOGRAPHY

Bergsagel PL, Kuehl WM, Zahn F, Sawyer J, Barlogie B, Shaughnessey J Jr. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood. 2005;106:296-303.

Kyle RA, Therneau TM, Rajkumar SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346:564-569.

Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Sem Hematol. 1995;32: 45-59.

Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78:21-33.

Royer B, Arnulf B, Martinez F, et al. High dose chemotherapy in light chain or light and heavy chain deposition disease. Kidney Int. 2004;65: 642-648.

Hideshima T, Bergsagel PL, Kuehl WM, Anderson KC. Advances in biology of multiple myeloma: clinical applications. Blood. 2004;104:607-618.

Rajkumar SV, Kyle RA. Multiple myeloma: diagnosis and treatment. Mayo Clinic Proc. 2005;80:1371-1382.

Have a question or comment about the ASH Teaching Cases? Please e-mail webmaster@hematology.org.